PLUS1
139.00
-0.66 (-0.47%)
-0.66 (-0.47%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | LLY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 139.66 | 138.46 | 144.60 | 140.92 | 139.66 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 41,960 | 4,013,280 | $ 140.70 | $ 564,668,175 | 6,229,438 | 101.36 - 148.16 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:40:10 | 15 | $ 139.00 | USD |
Eli Lilly Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 133.66B | 957.04M | $ 3.23B | 8.77 | 16.20 | 952.72M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 11.03M | $ 2.58 | 1.85% | 02/13/20 | - | - |
Eli Lilly News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/03/2020 | 12:43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 4/03/2020 | 07:29 | Dow Jones News | Recession Blue-Chips' Led the Way in Another Turbulent Week.. |
| 4/01/2020 | 16:00 | Business Wire | Medical Professionals Across Merck & Co., Inc., Pfizer Inc.,.. |
| 4/01/2020 | 13:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/31/2020 | 16:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/31/2020 | 11:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/31/2020 | 07:51 | Dow Jones News | Eli Lilly, Sitryx to Collaborate on Immunometabolic.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LLY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 130.65 | 144.60 | 129.29 | 138.15 | 5,045,003 | 9.01 | 6.9% |
| 1 Month | 136.42 | 144.60 | 116.55 | 133.52 | 6,545,940 | 3.24 | 2.38% |
| 3 Months | 135.78 | 148.16 | 116.55 | 136.35 | 5,025,718 | 3.88 | 2.86% |
| 6 Months | 107.20 | 148.16 | 101.36 | 128.69 | 4,043,515 | 32.46 | 30.28% |
| 1 Year | 129.24 | 148.16 | 101.36 | 121.54 | 4,071,031 | 10.42 | 8.06% |
| 3 Years | 84.13 | 148.16 | 73.69 | 108.79 | 4,794,563 | 55.53 | 66.0% |
| 5 Years | 71.13 | 148.16 | 64.18 | 97.49 | 4,591,623 | 68.53 | 96.34% |
Eli Lilly Description
| Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction. |
